Willow Biosciences Full Year 2023 Earnings: CA$0.10 loss per share (vs CA$0.12 loss in FY 2022)

[email protected] (Simply Wall St)
1 min read

In This Article:

Willow Biosciences (TSE:WLLW) Full Year 2023 Results

Key Financial Results

  • Revenue: CA$1.17m (up 43% from FY 2022).

  • Net loss: CA$13.0m (loss narrowed by 12% from FY 2022).

  • CA$0.10 loss per share (improved from CA$0.12 loss in FY 2022).

earnings-and-revenue-history
earnings-and-revenue-history

All figures shown in the chart above are for the trailing 12 month (TTM) period

Willow Biosciences shares are up 11% from a week ago.

Risk Analysis

We don't want to rain on the parade too much, but we did also find 3 warning signs for Willow Biosciences (2 are a bit concerning!) that you need to be mindful of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Recommended Stories